ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

40,300Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 151

$640K Total Retail Price of All Prescriptions

Rank: 36 out of 151

1,490 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,490 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 1,490 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 37,908 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$16 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 2,772 2,615 1 1
RANITIDINE HCL 1,633 1,485 10 2 32
AMLODIPINE BESYLATE 1,537 1,486 3 3
PANTOPRAZOLE SODIUM 1,466 1,354 10 4 34
METFORMIN HCL 1,380 1,284 5 8
ENALAPRIL MALEATE 1,350 1,263 10 6 38
LOSARTAN POTASSIUM 1,229 1,192 7 12
LISINOPRIL 1,165 1,117 8 5
ATENOLOL 1,074 1,022 9 11
OMEPRAZOLE 927 864 10 4
ATORVASTATIN CALCIUM 899 818 11 16
VIAGRA 767 708 12 74
ALPRAZOLAM 765 731 13 41
SYNTHROID 705 670 14 60
ALENDRONATE SODIUM 615 572 15 26
FENOFIBRATE 593 524 16 61
METOPROLOL SUCCINATE 577 569 17 21
HYDROCHLOROTHIAZIDE 536 528 18 13
TAMSULOSIN HCL 496 482 19 30
PAROXETINE HCL 480 477 20 54
FUROSEMIDE 461 415 21 6
METOPROLOL TARTRATE 419 394 22 7
LORATADINE 412 385 23 152
TEMAZEPAM 406 396 24 49
FOLIC ACID 404 355 25 140
WARFARIN SODIUM 393 361 26 9
DOXAZOSIN MESYLATE 392 380 27 77
GLIPIZIDE 362 342 28 43
NAPROXEN 358 342 29 93
FINASTERIDE 352 352 30 70
LOVASTATIN 322 308 31 31
ZOLPIDEM TARTRATE 294 282 32 17
GABAPENTIN 291 269 33 14
KLOR-CON 10 286 274 34 95
CARVEDILOL 280 259 35 22
CLOPIDOGREL 271 257 36 29
ALLOPURINOL 261 261 37 42
RENAL CAPS 248 231 38 220
LANSOPRAZOLE 234 233 39 118
DONEPEZIL HCL 230 224 40 15
CHERATUSSIN AC 223 214 10 41 224
LACTULOSE 220 220 42 101
LEVOXYL 217 215 43 179
FLUTICASONE PROPIONATE 216 200 44 35
VENTOLIN HFA 209 194 45 114
CETIRIZINE HCL 204 187 46 235
CLONAZEPAM 203 189 47 176
SERTRALINE HCL 201 200 48 25
PLAVIX 191 178 49 37
VITAMIN D2 188 167 50 242
AMLODIPINE BESYLATE-BENAZEPRIL 186 181 51 89
FAMOTIDINE 182 165 52 64
HYDRALAZINE HCL 182 180 52 84
CIALIS 181 163 54 210
IBUPROFEN 178 169 55 69
SURE COMFORT 177 154 56 174
DIOVAN 172 159 57 33
LANOXIN 160 155 58 253
NIFEDIPINE ER 152 152 59 83
GLYBURIDE 148 139 R 60 75
DILTIAZEM 24HR ER 138 138 61 213
ISOSORBIDE MONONITRATE ER 136 135 62 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 134 63 56
TERAZOSIN HCL 127 117 64 99
VERAPAMIL ER 123 115 65 112
TRAMADOL HCL 121 118 66 24
PROCTOZONE-HC 121 112 66 221
AMMONIUM LACTATE 120 105 68 173
SOTALOL 117 115 69 218
BENICAR 114 109 70 144
AMITRIPTYLINE HCL 114 101 R 70 156
VOLTAREN 113 104 72 116
CLOBETASOL PROPIONATE 112 97 73 211
OXYBUTYNIN CHLORIDE ER 111 110 74 166
TRIAMCINOLONE ACETONIDE 110 100 75 143
LOSARTAN-HYDROCHLOROTHIAZIDE 107 107 76 59
GLYBURIDE-METFORMIN HCL 103 101 R 77 107
ACETAMINOPHEN-CODEINE 102 98 S3 78 147
MIRTAZAPINE 101 101 79 28
MECLIZINE HCL 98 97 80 86
ADVAIR DISKUS 97 95 81 46
GLIMEPIRIDE 95 93 82 58
KETOCONAZOLE 93 89 83 151
LOPERAMIDE 90 87 84 283
BENAZEPRIL HCL 88 88 85 103
CICLOPIROX 86 81 86 263
FELODIPINE ER 86 65 86 164
FOLBIC 85 74 88 289
GEMFIBROZIL 85 82 88 104
LORAZEPAM 83 82 90 94
CRESTOR 83 78 90 27
GLIPIZIDE XL 82 82 92 202
NYSTATIN-TRIAMCINOLONE 82 78 92 165
CITALOPRAM HBR 81 70 94 18
CLOTRIMAZOLE-BETAMETHASONE 76 73 95 100
AVODART 76 76 95 169
TRADJENTA 75 70 97 295
DICLOFENAC SODIUM 74 67 98 109
PROPRANOLOL HCL 73 62 99 175
AFEDITAB CR 71 66 100 268
CILOSTAZOL 71 71 100 211
LABETALOL HCL 69 69 102 162
PRIMIDONE 65 58 103 231
NEXIUM 65 65 103 44
CLORAZEPATE DIPOTASSIUM 65 65 103 272
METOCLOPRAMIDE HCL 60 59 106 139
JANUVIA 59 59 107 97
BUTALBITAL-ACETAMINOPHEN-CAFFE 59 53 R 107 329
ATENOLOL-CHLORTHALIDONE 58 58 109 217
ACTOS 58 45 109 178
LANTUS SOLOSTAR 58 50 109 133
FLUOXETINE HCL 56 39 112 98
HYDROCODONE-ACETAMINOPHEN 54 47 S3 113 10
NAMENDA 53 53 114 20
LEVITRA 53 51 114 336
LANTUS 53 44 114 47
LEVOTHYROXINE SODIUM 51 51 117 2
CARBIDOPA-LEVODOPA 50 44 118 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.